Page 77 - Looking Statement News Today

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Acceleron Pharma Inc. (Nasdaq: XLRN), a publicly traded biopharmaceutical company, today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Acceleron for $180 per share ...

Ceridian will work with the Government of Canada to co-design and deliver intelligent HR and pay solutions for the federal public service.

Regulatory News: Technip Energies (PARIS: TE) and National Petroleum Construction Company (NPCC), a subsidiary of National Marine Dredging company, have signed a Memorandum of Understanding (MoU)

Merck known as MSD outside the United States and Canada, announced today that Leslie A. Brun, its independent lead director, has resigned from its Board of Directors, effective August 19, 2021. Mr. Brun is stepping down due to his decision to become chairman and chief executive officer of Ariel Alternatives, LLC, a subsidiary of Ariel Investments, LLC, a private equity initiative being created to help scale ...

Vancouver, British Columbia--(Newsfile Corp. - August 17, 2021) - Kodiak Copper Corp. (TSXV: KDK) (OTCQB: KDKCF) (FSE: 5DD1) (the "Company" or "Kodiak") announces that work has been temporarily halted

WELIREG Approved for Adult Patients With VHL Disease Who Require Therapy for Associated Renal Cell Carcinoma, Central Nervous System Hemangioblastomas, or Pancreatic Neuroendocrine Tumors, Not Requiring Immediate Surgery WELIREG Expands Merck’s Oncology Portfolio as the First and Only Systemic Therapy Approved for These Patients With VHL Disease Merck known as MSD outside the United States and Canada, today ...

KEYTRUDA Plus LENVIMA Is Now Approved for Two Types of Cancer, Including Advanced RCC Based on Phase 3 CLEARKEYNOTE-581 Trial, KEYTRUDA Plus LENVIMA Significantly Reduced Risk of Disease Progression or Death by 61% Versus Sunitinib Merck known as MSD outside the United States and Canada, and Eisai today announced that the U.S. Food and Drug Administration has approved the combination of KEYTRUDA, Merck’s anti-PD-1 ...

/PRNewswire/ - New Found Gold Corp. ("New Found" or the "Company") (TSXV: NFG) (OTC: NFGFF) is pleased to provide an update on its 100%-owned Queensway Project...

Burnaby, British Columbia--(Newsfile Corp. - August 12, 2021) - Tantalus Systems Holding (TSX: GRID) (the "Company" or "Tantalus") today announces that the Company has closed its previously announced

Clinical Data Supporting Approval Demonstrated Non-Inferior Immune Responses for the Serotypes Shared with PCV13 VAXNEUVANCE Elicited Superior Immune Responses for Serotypes 3, 22F and 33F Compared to PCV13, Which Are Major Causes of Disease known as MSD outside the United States and Canada, today announced the U.S. Food and Drug Administration approved VAXNEUVANCE ™ for active immunization for the prevention of … Clinical Data Supporting Approval Demonstrated Non-Inferior Immune Responses...